NeuroPace completes routine annual meeting, re-elects directors through 2029

Filed June 8, 2026 · Period ending June 5, 2026 · ~1 min read

Key Changes

• low

  Stockholders re-elected Lisa Andrade and Scott Huennekens as Class II directors to serve three-year terms until the 2029 annual meeting. Both nominees received majority support with Huennekens garnering 99% approval.

  Item 5.07 verify on EDGAR →
• low

  Stockholders ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 with 99% approval. No change in auditor relationship.

  Item 5.07 verify on EDGAR →